Introduction
The prevalence of paediatric obesity remains alarmingly high (1) (2) (3) (4) (5) (6) . Given the known health risks (7) (8) (9) (10) (11) (12) (13) , societal burden (14) , and healthcare costs (14) , managing and preventing this disease are a public health priority. A number of behavioural interventions to address paediatric obesity have been reported, yet interventions that produce reliable, long-term impacts on child weight are rare (15) (16) (17) (18) (19) . Obtaining a better understanding of why some of these interventions have not led to desired outcomes is critical for informing the development of more effective interventions in the future. Without information on treatment fidelity (defined as treatment design, provider training, and treatment delivery, receipt and enactment (20) ), it is difficult to interpret null findings and to replicate significant ones. For example, in the absence of information on treatment fidelity, it is impossible to determine whether the treatment itself is not efficacious or whether the intervention was not delivered as intended. Reporting findings from treatment fidelity methods is a critical step in moving the field forward, as an improved focus on fidelity may ultimately lead to enhanced treatment efficacy (20) . Treatment fidelity has become even more important with the increasing focus on multicomponent behavioural obesity interventions. Without in-depth descriptions of fidelity for each intervention component, it is unclear which components worked and which did not. Clear, detailed and consistent documentation of treatment fidelity across the field will help researchers improve future interventions.
The first step in improving treatment fidelity is to determine which components are typically measured and reported across the field. Very little is known about current practices in paediatric obesity research (21) . Authors of multiple systematic reviews have commented on the lack of published information available to evaluate treatment fidelity as a predictor of treatment outcomes, estimating that measurement of any component of fidelity was reported only 5-30% of the time (22) (23) (24) (25) (26) . None of these reviews provide detailed information on what is or is not published. It is not clear which components of treatment fidelity are commonly used; only that use is relatively low across the field. Tools have been developed to assist researchers in standardizing the measurement and reporting of treatment fidelity. The Template for Intervention Description and Replication (TIDieR) checklist gives specific guidance on what to present (21) but does not address items specific to behavioural interventions. The Workgroup for Intervention Development and Evaluation Research (WIDER) checklist is another tool promoting a standardized approach to treatment fidelity in randomized controlled trials (RCTs) (22) . It includes elements of the TIDieR checklist and adds specific items related to behavioural interventions (e.g. behavioural change techniques). The National Institutes of Health (NIH) Treatment Fidelity Framework, designed by the Behaviour Change Consortium, includes similar items to the TIDieR and WIDER checklists but further breaks down fidelity into five domains (i) treatment design; (ii) provider training; (iii) treatment delivery; (iv) treatment receipt and (v) treatment enactment (27) . This is the most detailed tool available and has been used to explore the quality of reporting in other health behaviour fields and across behaviour change research more broadly (28) (29) (30) . This review is the first to use this tool to explore treatment fidelity in paediatric obesity interventions.
The NIH Treatment Fidelity Framework (27) proposes that all five domains of treatment fidelity are necessary when reporting the results of intervention trials. (i) Treatment design refers to how an intervention was intended to be delivered and includes theoretical frameworks, intended dose, intended content and intended qualifications of treatment providers; (ii) The provider training component addresses what specific methods will be used to train providers and maintain provider skills throughout the intervention; (iii) Treatment delivery corresponds to how well the providers adhere to the intended treatment and includes information about actual dose and content delivered, as well as the measurement of non-specific factors; (iv) Treatment receipt refers to how well the intervention addresses participants' comprehension of and ability to use learned skills during treatment sessions and (v) treatment enactment refers to participants' ability to use these skills outside of formal treatment sessions. Failing to measure and report any one of these components inhibits readers' ability to interpret findings. There is a clear need for improved reporting of treatment fidelity, which will ultimately lead to improved efficacy of future behavioural paediatric obesity interventions.
The current systematic review aims to describe in detail how the childhood obesity prevention and management field reports components of treatment fidelity in RCTs. Specifically, we aim to (i) identify which domains of treatment fidelity are most commonly used in the field; (ii) describe what methods are used to measure these domains; (iii) examine associations between treatment fidelity and study quality, number of study articles reviewed and publication year and (iv) make specific recommendations for more rigorous measurement and reporting of treatment fidelity. Based on previous work, it is hypothesized that treatment design will be the most consistently reported domain and that study quality, number of articles reviewed and publication year will all be positively associated with treatment fidelity. Throughout this article, the term 'treatment' fidelity is used to refer to the fidelity of any interventions aimed at either treating or preventing obesity as this is the term that is consistently used in other fields. Understanding how treatment fidelity is currently used by researchers in this field can lead to the development of best practice guidelines and ultimately to more efficacious interventions.
Methods

Protocol and registration
This review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (31) . All methods were specified in advance and documented in a protocol. The protocol was registered on PROSPERO (Registration #CRD42016036124, date registered 11 March 2016) and can be accessed here: www.crd. york.ac.uk/PROSPERO/display_record.asp?ID = CRD4201 6036124.
Information sources and search strategy
A trained health sciences librarian with experience in conducting and documenting searches for systematic reviews performed an extensive search of the literature to identify intervention studies or RCTs on the management or prevention of paediatric obesity published in the English language. The PubMed (Web-based), Cumulative Index to Nursing and Allied Health Literature (EBSCO platform), PsycINFO (Ovid platform) and EMBASE (Ovid platform) databases were used in this systematic review. Dissertations, books, book chapters and conference proceedings/abstracts were excluded. In PubMed, the medical subject headings terms defined the concepts of obesity, overweight or body mass index; treatment, therapy or prevention; children, childhood, adolescents or paediatric (under 18 years of age); and RCTs or intervention studies. For optimal retrieval, all terms were supplemented with relevant title and text words. Full PubMed search parameters are available on PROSPERO. The search strategies for Cumulative Index to Nursing and Allied Health Literature, PsycINFO and EMBASE were adjusted for the syntax appropriate for each database using a combination of thesauri and text words. Published reports in the peer-reviewed literature from January 1990 to March 2014 were identified. If an article for a given study met the inclusion criteria and other ancillary study articles were referenced but not identified in the original search (e.g. published after March 2014), these articles were identified and included. Study authors were not contacted to identify additional information, as the primary purpose of this systematic review was to evaluate what is reported in the available literature. Finally, bibliographies from selected key systematic review articles were scanned to identify additional publications.
Study selection process
Articles were independently evaluated for selection in a two-step process by a group of eight coders. First, titles and abstracts of all identified articles were reviewed by two independent reviewers to make initial exclusions. Exclusion reasons were recorded. All discrepancies were adjudicated by the lead reviewer (M. M. J.) and discussed with the secondary reviewer when necessary. Then, two reviewers independently read full texts of articles that were not excluded earlier to determine final selection for inclusion. Studies that did not meet inclusion criteria were removed at that time, and reasons for exclusion were documented. Differences were again adjudicated by the lead reviewer (M. M. J.) and discussed with secondary reviewers when needed. Although all records were reviewed by two reviewers and differences were adjudicated, intercoder agreement for this step was evaluated. Articles from a single study were then combined into a single record, and all study records were imported into REDCap (32) . Included studies were published randomized trials testing behaviour change interventions to impact weight status of children between the ages of 2 and 18 at the time of randomization. Table 1 includes detailed information about inclusion and exclusion criteria with reference to PICOS (participants, interventions, comparisons, outcomes and study design) (31) . This review was designed to evaluate the reporting of treatment fidelity within high-quality studies to minimize the potential effect of reporting bias. Thus, only RCTs (thought to be the gold standard study design) were included. However, no selection criteria were specified for comparison groups as treatment fidelity was only evaluated for a single-treatment group within each trial. No between-group comparisons were made. If a trial contained more than one active intervention arm, only one was selected for review using the following criteria: (i) in person or individually delivered intervention arms were selected over other modes or formats; (ii) enhanced or multicomponent intervention arms were selected over standard or single-component and (iii) parent and child intervention arms were selected over parent only or child only. If multiple articles for a given study were identified based on the selection criteria in Table 1 (i.e. "Study articles reporting intervention descriptions…"), then all of these articles were used for extraction. An intentionally broad range of interventions was also chosen for this project, including studies targeting participants from any country and participants with chronic or mental health conditions.
Data extraction process and elements
After studies were identified for inclusion, basic information about the study population, study design and selected intervention arm was extracted. Each study was also coded for study quality as measured by the Delphi checklist (a nineitem checklist with yes or no response options developed to evaluate quality assessment in RCTs) (33) . Treatment fidelity was evaluated using a modified version of the NIH Treatment Fidelity Framework (27) . For training purposes, a random sample of 10 studies were identified and coded by all three coders. To complete certification of coding, it was intended that the two secondary coders would complete sets of 10 additional studies along with the lead coder. Intercoder agreement would be calculated after each set of 10 articles was completed until reliability (as measured by prevalence-adjusted and bias-adjusted Kappa, PABAK (34)) was above 0.80 for all items. Because of the large variability in reporting across the studies, the decision was later made to have two coders independently code all studies. Coders met bi-weekly throughout the coding process to refine operational definitions and adjudicate differences. The author of the NIH Treatment Fidelity Framework was contacted when additional clarification on items was needed. Three measures of inter-coder reliability (PABAK, standard Kappa and % agreement) were used to calculate reliability of all items in the tools subsequently.
Treatment fidelity review M. M. JaKa et al. 3 obesity reviews Treatment fidelity (National Institutes of Health treatment fidelity framework) Treatment fidelity was coded using a modified version the NIH Treatment Fidelity Framework. The framework includes five primary domains of fidelity: treatment design, provider training, treatment delivery, treatment receipt and treatment enactment. Items within each domain were coded as present or absent. If an intervention was multicomponent, a fidelity indicator was marked present if it was described for at least one component. Modifications to the original framework are presented in Table 2 . Specifically, one item (treatment design information about intended content) was split into three items to provide more details. Because consensus on the discrete components of intervention content does not yet exist, we built on work in other fields to specify three components: (35, 36) behaviour change techniques, target behaviours and therapeutic alliance. Next, the original item related to dose delivered was expanded to mirror the three dose-intended items, putting increased emphasis on this component. Lastly, a single item was added to evaluate content delivered. This item was not split into the three content components as was carried put earlier, because of the very limited reporting of these items. Three items were excluded from the framework for this synthesis. The first, regarding the comparison arm, was excluded as only a single intervention group was evaluated. The remaining two were excluded as a reliable operational definition that could not be reached. Domain summary scores were calculated for each study by summing the number of items coded as present.
Study quality (Delphi checklist)
The Delphi checklist (33) was used to measure study quality. This checklist was designed to evaluate the quality assessment of RCTs. It includes nine items with yes or no response options developed using a Delphi consensus procedure. The final items included (i) was a method of randomization performed; (ii) was treatment allocation concealed; (iii) were randomized groups similar at baseline; (iv) were eligibility criteria specified; (v) was the outcome assessor blinded; (vi) were participants blinded; (vii) were treatment providers blinded; (viii) were point estimates and measures of variability reported for the primary outcome and (ix) was an intentto-treat analysis included. A summary score was calculated by summing the number of yes's coded for a single study.
Summary measures and analysis
Descriptive statistics including counts, frequencies, means and standard deviations were calculated for all items when • Prescribed diet or exercise or environmental interventions with no behavioural component • Interventions delivered entirely during the school day or community-wide interventions where fidelity cannot be feasibly measured at the individual or family level Outcome
• Objective measure of child weight outcome (e.g. BMIz or % overweight) Study design
• Individual or group randomized controlled trials published as original articles
• Observational studies (e.g. developing but not testing interventions, developing theoretical frameworks, validating outcome measures, correlates of obesity, case studies, cohort studies or case-control studies)
• Quasi-experimental studies (e.g. pre/post studies or nonrandomized control group) • Study articles published after 1990
• Cross-sectional (as opposed to cohort) group randomized trials • Study articles published in English
• Secondary syntheses of randomized controlled trials not likely to report on treatment fidelity (e.g. study recruitment or study measure development) • Study articles reporting intervention descriptions or fidelity data for the primary intervention (e.g. design papers, process evaluations and cost-effectiveness analyses)
• Secondary syntheses of existing literature (e.g. systematic reviews, commentaries or book chapters) • Unpublished works (e.g. dissertations or abstracts) PICOS, participants, interventions, comparisons, outcomes and study design. 
supervision or ongoing training). Treatment delivery
Provided information about dose delivered The next three items were added for this review.
Length of contact sessions
Must report session length either delivered or received (e.g. average session length).
Number of contact sessions
Must report the number of participants completing some portion of the treatment.
Duration of treatment
Must report the average duration actually delivered or received across participants.
Provided information about content delivered
This item was added for this review. Must report actual content delivered during treatment sessions. 5. Method to ensure that content was delivered as specified Must report method used during sessions with intent of improving content delivery. 6. Method to ensure that dose was delivered as specified Must report method used during sessions with the intent of improving dose delivery. 7. Method to assess if the provider adhered to the content Must report method used to evaluate and report actual content delivered. 8. Assessed non-specific treatment effects May include participant satisfaction; therapeutic alliance methods not included. 9. Used a treatment manual Must state 'treatment manual' or report written instructions given to providers. Treatment receipt 1. Assessed subject comprehension of the intervention during the intervention period
Must be a method used by the treatment team to assess skills learned during the intervention period; methods used by the evaluation team are not included. X Strategy to improve subject comprehension of the intervention This item was not coded for this review.
2. Assessed subject ability to use the intervention skills during the intervention period Must be assessment of skills during the treatment session (e.g. evaluation role play) by the treatment team; methods used by the evaluation team are not included. X Strategy to improve subject performance of intervention skills This item was not coded for this review.
Treatment enactment 1. Assessed subject performance of the intervention skills in settings which the intervention might be applied
Must mention assessment of learned skills performed outside treatment sessions by the treatment team; methods used by the evaluation team are not included. X Strategy to improve subject performance of intervention skills in settings which the intervention might be applied This item was not coded for this review.
Treatment fidelity review M. M. JaKa et al. 5 obesity reviews appropriate. Three measures were used to calculate intercoder agreement as recommended by the Guidelines for Reporting Reliability and Agreement Studies (37) . The PABAK was calculated in addition to traditional measures (Cohen's kappa and % agreement) as it may be more appropriate when the prevalence of an endorsed item is low (34) . A study quality score (Delphi index) and treatment fidelity scores (overall and by domain) were calculated for each study by summing the total number of items present for a given study. Associations between the outcome of overall treatment fidelity (possible range: 0 to 26) and predictors (i) study quality (possible range: 0-9); (ii) publication year (in quartiles) and (iii) number of articles reviewed per study (1 vs. >1) were evaluated using general linear regression. Statistical significance was considered a p-value less than 0.05. All analyses were conducted using SAS 9.3.
Results
Study selection and data extraction process 
Descriptive characteristics of included studies
Descriptive information for the 193 included studies is presented in Table 3 . Most of the studies were individually randomized trials, conducted in the USA and published after 2008. Average study quality, as measured by the Delphi checklist, was 4.7 (SD = 1.4) out of nine possible items. The sample for this systematic review was limited to RCTs, and thus, all of the included studies reported some method of randomization. Because of the type of interventions included in this review, none had providers who were blinded to treatment condition, and very few had participants who were blinded to treatment condition (N = 5, 3%). Almost all studies reported point estimates and measures of variability for one or more weight outcomes (N = 178, 92%), and almost all specified eligibility criteria (N = 168, 88%). More variability was seen in the remaining items. The inter-coder agreement for the Delphi study quality items was high, with a mean (SD) for PABAK, Kappa and % agreement of 0.85 (0.12), 0.53 (0.31) and 0.92 (0.06), respectively. Few studies included children in the normal weight range. Most studies evaluated in person interventions delivered in university or clinic settings. The selected interventions were evenly split between group and individual treatment, or the combination. Most intervened on both parents and children and targeted diet and physical activity combined.
Reporting of treatment fidelity in included studies
The overall inter-coder agreement for this measure was high with a mean PABAK across all items of 0.83 (SD = 0.09). Coders had near-perfect agreement (0.80 to 1.00) for 79% of items, substantial agreement (0.60 to 0.79) for 17% of items and moderate agreement (0.40 to 0.59) for only 4% of items (38) . The mean Kappa was 0.55 (SD = 0.23), and the mean % agreement was 0.92 (Table S1 ). The results from the NIH Treatment Fidelity Framework are presented in Fig. 2 . There was large variability in reporting of treatment fidelity across the five domains; treatment design elements were reported with the highest frequency. Proportion of specific items ranged from 4% (treatment enactment: reporting method to assess participant comprehension) to 99% (treatment design: reporting target behaviours). Eightyseven percent of studies (N = 168) reported less than half the items. Individual study results are provided in the Supporting information (Table S2 ). The specific methods used to report selected constructs within each domain are reported in Table 4 and described subsequently.
Treatment design
The percent of studies reporting some information on the intended dose was high (ranging from 77% to 94%), although the methods of the reporting varied largely as shown in Table 4 . Almost all studies reported at least some information about the behaviour change techniques used and the targeted weight-related behaviours, but again, the variability in the methods with which these were reported was high. Very few used standard definitions of behaviour change techniques such as the behaviour change technique Treatment fidelity review M. M. JaKa et al. 7 obesity reviews taxonomy (BCTTv1) (39) . Information about the approach to addressing therapeutic alliance was not commonly reported. The most common method was to use a consistent therapist to deliver all sessions for a given participant. Provider credentials were reported more commonly and often included profession, education or both. Some gave provider characteristics in addition to credentials (e.g. gender and race/ethnicity), which were not captured by this tool. Over half the studies mentioned some theoretical framework or clinical guideline. Common theoretical models were socialecological model or social-cognitive theory; common types of therapy were motivational interviewing or cognitivebehavioural therapy.
Provider training
Few studies provided details on the training protocols for their providers. Some authors mentioned that providers were trained or reported the content or length of the training. These instances are not captured by this tool. The reporting of how provider skills were maintained over the course of the intervention was more common. The methods for maintaining skills most often included ongoing supervision or booster trainings.
Treatment delivery
Overall reporting of treatment delivery was lower compared with the treatment design domain. Information about the dose or content delivered was not often reported, with the exception of number of contact sessions (74%). The most common way to report number of sessions delivered was to report the number of participants with session attendance in categories (e.g. N participants completed the intervention, N participants were high attenders or N participants completed at least half of the intended sessions). Of those who reported the amount of content delivered during sessions (N = 17), three (18%) reported specific behaviour change techniques, and four (24%) reported the weightrelated behaviours targeted.
Treatment receipt and enactment
Methods to assess participant receipt during treatment sessions were the least likely to be reported relative to the other four domains. Some examples of the methods used to assess participant comprehension of content were in session quizzes or asking participants to recall treatment messages.
Methods to assess participants' use of intervention skills were most common in group physical activity programs and included the accelerometers or heart rate monitors to determine if children were able to maintain a certain intensity of activity. Measurement of participant enactment of skills outside of treatment sessions was more commonly assessed than receipt of these skills. The most common example of this was the provider review of self-monitoring logs.
Treatment fidelity and study quality, number of included articles, and publication year
The summary scores for the NIH Treatment Fidelity Framework are provided in Table 5 . There was a statistically significant positive association between study quality as measured by the Delphi checklist and treatment fidelity (β = 0.61, p < 0.01). There was also a statistically significant association between the number of articles included for a given study and treatment fidelity, with higher fidelity reporting by studies with more than one included article (β = 1.8, p < 0.01). There was no relationship between publication year and treatment fidelity (β = 0.20, p = 0.26).
Discussion
The primary aim of this systematic review was to understand how behavioural paediatric obesity interventions 8 Treatment fidelity review M. M. JaKa et al. obesity reviews obesity reviews report treatment fidelity within RCTs. Historically, the 'treatment fidelity' framework has been used in clinical fields (e.g. psychotherapeutic treatment studies). With this review, we have shown that treatment fidelity is highly relevant, but not fully reported, in behavioural intervention studies designed to prevent and manage obesity. Across this field, researchers were largely successful in reporting treatment design, including identification of theoretical frameworks guiding the intervention development. This is consistent with findings from those who have reviewed literature using the NIH Fidelity Framework in other fields (27, 29, 30) . Within treatment design, reporting of elements related to therapeutic alliance was relatively low. This item was added by the current research team under the treatment design domain (not within non-specific factors under treatment delivery), as studies in clinical psychotherapy settings have consistently found it to be an essential component of participant engagement and treatment outcomes (36) . While the term 'therapeutic alliance' (i.e. the quality of the therapist-client relationship) has its origins in clinical psychotherapy settings, the concept is broadly applicable to any person-to-person intervention in which there is a relationship between the participant and interventionist (e.g. cognitive, behavioural and psychoeducational). Therapeutic alliance has been widely studied in both intervention and prevention trials (e.g. family-based substance abuse prevention, family-based interventions for at risk youth and relapse prevention) and has been consistently shown to be a major variable in explaining both dropout rates and treatment efficacy (40, 41) . Thus, it should be adequately addressed during the design phase. Our findings also indicate that some aspects of treatment delivery, including number of sessions and participant satisfaction with the intervention, are reported at a high frequency. Other aspects of treatment delivery, such as length of session and content delivered, are reported very infrequently. Findings from this review highlight additional areas for improvement with respect to treatment fidelity reporting. Components in the domains of provider training, treatment receipt and treatment enactment were infrequently reported. This is in contrast to reviews utilizing the NIH Fidelity Framework in other areas that found higher reporting of enactment (42, 43) . It should be noted that one enactment item (Reporting use of a strategy to improve subject performance of intervention skills) was excluded from this review, as adequate reliability could not be obtained. This is likely because of the low prevalence and high variability in methods of this item across this field. The importance of provider training was highlighted in recent research of Brose et al. (44) that found availability and use of a training manual were associated with better outcomes for smoking cessation interventions (44) . Further, using more robust methods to evaluate participant receipt and enactment can highlight potential breakdowns in the pathway from treatment design 10 Treatment fidelity review M. M. JaKa et al. obesity reviews to participant outcomes. As shown in Table 4 , there is room for improvement in the quality of methods selected to measure fidelity within each domain. Within the field, emphasis has been placed on moving towards objective, valid and reliable methods to measure study outcomes (e.g. physical activity). This same emphasis should be placed on using rigorous methodology to measure treatment fidelity. For example, only one of the 44 studies reporting a method to assess treatment enactment used an objective measure (specifically, observation of home environment or behaviours).
In examining specific studies for completeness, only a single study (of 193 evaluated) included at least one item from each of the five domains, and this study (the HIKCUPS study) was tied for the highest proportion of reported items at 71%. This is notable in that Borrelli et al. highlight the mutually exclusive nature of the five domains (27) . Inattention to one domain could threaten the internal validity of a study. It is important to mention that reporting on treatment fidelity may be diminished because of space limitations in journals as opposed to what was actually implemented. Again, this may reflect prioritizing outcome evaluation over treatment fidelity evaluation. It is necessary to report information about each of these domains to fully understand the quality of the intervention and nuances of implementation. In addition, this would allow standardized comparisons between interventions so that the specific components that produce behaviour changes may be identified. To address space limitations, authors should consider publishing separate articles addressing treatment fidelity. We found that the number of published articles included for a given study was associated with reporting of treatment fidelity. The aforementioned HIKCUPS study had nine published articles included in this review (the most of any included study). Two of these articles focused heavily on treatment fidelity, one on study design (45) and one on process evaluation (46) . This multi-paper approach allowed the authors to dedicate significant space to the description of treatment fidelity components and may have contributed to their success in addressing all five domains.
The current review also sought to examine associations of treatment fidelity and study quality. It could be posited that those designing more rigorous studies may also design more rigorous treatment fidelity methods, thus having better reporting. In this review, there was a positive and significant association between study quality and treatment fidelity. Still, within the highest-quality studies (six or more items on the Delphi checklist, N = 49 studies), an average of only 37% (SD = 11%) of treatment fidelity items was reported. Interestingly, this study found no association between treatment fidelity reporting and year of publication, contrary to the findings of interventions to address second hand smoke (43) . This is further evidence that efforts are needed to help researchers improve their published descriptions of treatment fidelity. As a first step, detailed recommendations for improving treatment fidelity reporting are presented in Table 6 . Additionally, we urge researchers within the field to continue refining the available treatment fidelity reporting tools and to develop and publish rigorous methods for reporting specific items within the treatment fidelity domains.
Funding agencies and professional organizations can also help obesity researchers to become leaders in treatment fidelity. Specifically, funders could require applicants to describe methods to assess treatment fidelity within grant applications. As mentioned previously, treatment design elements were the most commonly reported fidelity domains in this review, which is likely because of the inclusion of these items in the research plan methodology of grant applications. Requiring investigators to include all components of treatment fidelity may motivate researchers to more intentionally measure the multiple domains of treatment fidelity. However, it is important to note the additional costs associated with this level of methodological rigor and will have budget implications which should be anticipated by funding agencies. Professional organizations and associated journals can also aid in moving forward the science by requiring the use of existing checklists (e.g. WIDER, TiDiER or NIH Fidelity Framework checklists) by authors during submission and during the peer review process. To further encourage work in this area, obesity researchers should propose symposia focusing on treatment fidelity at national obesity meetings and those who sit on editorial boards should bring these issues forward. Finally, journals could offer submission categories for treatment fidelity articles, analogous to the 'Study Design, Statistical Design and Study Protocols' option offered by contemporary clinical trials.
This systematic review has a number of strengths that bolster the findings. Inter-coder reliability was high and comparable to other systematic reviews using this measure (27, 42, 43, 47) . Further, a thorough approach to coding was taken, such that two reviewers independently coded all studies and adjudicated differences. This project undertook an expansive review with broad inclusion criteria spanning a 24-year period to fully capture the state of the field. Third, strong methodology was employed, i.e. following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, following reliability reporting recommendations to include multiple measures of reliability at each step and for each item (Table S1 ), registering the review on PROSPERO along with publication of the search strategy, and including the entire data table in the Supporting information (Table S2) . Finally, this work went beyond looking simply at the presence of treatment fidelity items to characterizing the specific methods used by research teams, which have been a noted limitation of previous reviews.
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There are limitations that should be noted. Incomplete descriptions of intervention components within a treatment arm made evaluating fidelity by treatment component (e.g. home visits vs. group classes) impossible. To address this in the future, authors should be clear in defining the designed setting, participants and mode. Similarly, multiple interventions are often compared in RCTs; however, this project focused exclusively on fidelity reporting in one intervention arm, selected by the reviewers. Authors should be urged to report detailed treatment fidelity for each component of all intervention groups whether or not they are the primary intervention of interest. This would allow future systematic reviews to compare fidelity between study arms. Lastly, the current review did not evaluate the level of fidelity within a study (e.g. adequacy of the reported dose or content delivered). Future systematic reviews can use treatment fidelity to answer important questions, such as determining the optimal treatment dose for behavioural paediatric obesity interventions. Researchers have begun to examine associations between intervention content and outcomes (48) (49) (50) (51) . However, this work is hampered by low levels of fidelity reporting across the field. By giving more attention to the reporting of all components of treatment fidelity, from design to enactment, it is likely that these components will be better implemented, and the effectiveness of paediatric obesity interventions will improve. • Report intended dose in terms of length (e.g. minutes), number, duration (e.g. months), pace (e.g. constant or tapered) and density (e.g. weekly).
• Clearly distinguish between treatment duration and study duration, as well as which sessions are intended to deliver treatment and which are intended to collect data for study evaluation.
• Use consistent definitions of behaviour change techniques (e.g. the behaviour change technique taxonomy, BCTTv1 (39)).
• Use theoretical frameworks to guide choice of behaviour change techniques (e.g. intervention mapping (52)).
• Report detailed information about the behaviours targeted within diet and physical activity (e.g. fruit and vegetable intake or portion control). A consistent taxonomy of target behaviours for paediatric obesity interventions should be developed.
• Clearly distinguish between intended components (e.g. dose, content and provider credentials) and what was actually delivered.
• Report relevant provider characteristics (e.g. years of experience, gender and race/ethnicity) in addition to academic or professional credentials.
• Report information on how specific constructs from theoretical frameworks were chosen (e.g. APEASE criteria (35)). Provider training
• Provider training should be tailored based on baseline provider skills assessments or and this information should be reported (53) .
• Provider training should be reported as both what was intended and what was ultimately delivered.
• Detailed information about provider training should also include information about the content and dose of the training.
• Utilize and report provider certification prior to delivering treatment, with a gold standard method of directly observing and coding standardized certification sessions.
• Identify appropriate evidence-based methods to maintain provider skills over time (e.g. clinical supervision) (42) . Treatment delivery
• Report detailed information on the mode, setting and format of sessions actually delivered if different from originally designed.
• Report detailed information on the dose (e.g. length, number, duration, pace and density of sessions delivered) and content (e.g. behaviour change techniques and target behaviours) actually delivered across all participants randomized to the treatment.
• Use direct observation or recordings to code and report content delivered to avoid self-presentation bias that may occur if relying on provider report (54). Conversely, if the purpose of having a provider report treatment delivery is to improve adherence, the method should be completed by the provider during treatment sessions.
• Non-specific factors are not systematically measured, and the definitions are not clear in the literature (55) . However, best practice would be to have an independent observer code for the delivery of non-intended behaviour change techniques and to have participants report satisfaction.
• Publish treatment manuals as supporting documents.
Treatment receipt
• Distinguish between dose/content delivered and dose/content received, which may vary depending on the mode of delivery (e.g. e-mail vs. in person) or the treatment format (e.g. individual vs. group).
• Analogous to treatment delivery, (i) utilize provider methods (e.g. in session skills assessments) to ensure treatment receipt during intervention sessions and (ii) independently evaluate participant receipt for reporting purposes. Validated methods and tools should be developed for use within the field. Treatment enactment
• Utilize methods to report participant enactment of learned skills during the treatment period (but outside of treatment sessions) and participant enactment after the treatment period has concluded. The latter may be thought of as participant retention of skills.
• As with treatment delivery and receipt, use provider-completed methods (e.g. provider observation of participant behaviours in vivo) to ensure enactment and independent evaluation of participant enactment for reporting purposes.
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